Journal for ImmunoTherapy of Cancer (Nov 2023)

333 Empowering cancer immunotherapy by mesothelin-directed CAR T cells engineered to secret checkpoint inhibitors

Jiantao Wang,
Huajing Wang,
Xian-Yang Li,
Xiaowen He,
Xinran Luo,
Zhenwei Zhong

Affiliations

Jiantao Wang: Ophthalmology, Shenzhen Eye Hospital, Shenzhen Key Laboratory of Ophthalmology, Shenzhen University School of Medicine, Shenzhen, Guangdong, China
Huajing Wang: Oricell Therapeutics, Shanghai, China
Xian-Yang Li: Oricell Therapeutics, Shanghai, China
Xiaowen He: Oricell Therapeutics, Shanghai, China
Xinran Luo: Oricell Therapeutics, Shanghai, China
Zhenwei Zhong: Oricell Therapeutics, Shanghai, China

DOI: https://doi.org/10.1136/jitc-2023-SITC2023.0333
Journal volume & issue: Vol. 11, no. Suppl 1

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal